Basic Information
Basic information for ITGA9-AS1-202-46aa
Peptide Name ITGA9-AS1-202-46aa
Genome Position chr3:37749135-37749272[-]
Species Human
Peptide Sequence MEVTETSKSKEGEEKAEHETRGRNRICRGIKKVSRSLETESRLAVA
Peptide Length 46
Unique No (ITGA9-AS1-218-46aa,ITGA9-AS1-223-46aa,ITGA9-AS1-225-46aa,ITGA9-AS1-228-46aa,ITGA9-AS1-235-46aa,ITGA9-AS1-236-46aa)
Grand Average of Hydropathicity -1.1674
Relative Molecular Mass 6028.67
Experimental Evidences no
lncRNA ID/Name ENSG00000235257;ITGA9-AS1
Transcript ID/Name ENST00000420870;ITGA9-AS1-202
Transcript Length 1338
Coding Ability 0.3543
DNA Sequence Corresponding to Peptide ATGGAGGTCACAGAGACCAGTAAGAGCAAGGAGGGAGAGGAAAAAGCTGAACATGAAACTCGAGGAAGAAACAGAATATGCAGAGGAATAAAAAAAGTGAGTAGATCTCTAGAGACAGAAAGTAGATTAGCGGTTGCC
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :